Search
iSpecimen Inc
ISPCAdd to Watchlist
2.640USD
-0.090-3.30%
Close 07/02, 13:00（ET）Quotes delayed by 15 min
48.94KMarket Cap
LossP/E TTM
More Details of iSpecimen Inc Company
iSpecimen Inc. is a technology-driven company. The Company addresses a critical challenge, which focuses on connecting life science researchers who need human biofluids, tissues, and living cells (biospecimens) for their research. The Company’s iSpecimen Marketplace platform is designed to solve this problem and transform the biospecimen procurement process to accelerate medical discovery. Its technology consolidates the biospecimen buying experience in a single, online marketplace that brings together healthcare providers who have biospecimens and researchers across industry, academia, and government institutions who need them. In addition to providing the technology platform to connect researchers and healthcare providers, the Company handles all marketing, sales, contracting, and compliance functions across both sides of the marketplace. The iSpecimen Marketplace technology comprises four functional areas: search, workflow, data and administrative, compliance and reporting.
iSpecimen Inc Info
Ticker SymbolISPC
Company nameiSpecimen Inc
IPO dateJun 17, 2021
CEOField (Katharyn)
Number of employees24
Security typeOrdinary Share
Fiscal year-endJun 17
Address8 Cabot Road
CityWOBURN
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryUnited States of America
Postal code08101
Phone17813016700
Websitehttps://www.ispecimen.com/
Ticker SymbolISPC
IPO dateJun 17, 2021
CEOField (Katharyn)
Company Executives of iSpecimen Inc
Name
Name/Position
Position
Shareholding
Change
Mr. Avtar Dhaliwal
Mr. Avtar Dhaliwal
Independent Director
Independent Director
--
--
Ms. Katharyn (Katie) Field
Ms. Katharyn (Katie) Field
President, Chief Executive Officer, Treasurer, Secretary
President, Chief Executive Officer, Treasurer, Secretary
--
--
Ms. Yuying Liang, CPA
Ms. Yuying Liang, CPA
Chief Financial Officer
Chief Financial Officer
--
--
Ms. Siyun Yang
Ms. Siyun Yang
Independent Director
Independent Director
--
--
Mr. Anthony Lau
Mr. Anthony Lau
Independent Director
Independent Director
--
--
Mr. Arphing (Tommy) Lee
Mr. Arphing (Tommy) Lee
Independent Director
Independent Director
--
--
Name
Name/Position
Position
Shareholding
Change
Mr. Avtar Dhaliwal
Mr. Avtar Dhaliwal
Independent Director
Independent Director
--
--
Ms. Katharyn (Katie) Field
Ms. Katharyn (Katie) Field
President, Chief Executive Officer, Treasurer, Secretary
President, Chief Executive Officer, Treasurer, Secretary
--
--
Ms. Yuying Liang, CPA
Ms. Yuying Liang, CPA
Chief Financial Officer
Chief Financial Officer
--
--
Ms. Siyun Yang
Ms. Siyun Yang
Independent Director
Independent Director
--
--
Mr. Anthony Lau
Mr. Anthony Lau
Independent Director
Independent Director
--
--
Mr. Arphing (Tommy) Lee
Mr. Arphing (Tommy) Lee
Independent Director
Independent Director
--
--
FAQs
Who are the top five shareholders of iSpecimen Inc?
The top five shareholders of iSpecimen Inc are: Mr. Avtar Dhaliwal
How many institutions hold shares of iSpecimen Inc (ISPC)?
As of 2026Q1, 31 institutions hold shares of iSpecimen Inc, with a combined market value of approximately 5.11K, accounting for 0.39% of the total shares. Compared to 2025Q4, institutional shareholding has increased by -79730.00.
What is the biggest source of revenue for iSpecimen Inc?
In 2026Q1, the Specimens – contracts with customers business generated the highest revenue for iSpecimen Inc, amounting to 95.82K and accounting for 89.89% of total revenue.